TaiwanJ Pharmaceuticals Co., Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 61.720 million compared to TWD 0 a year ago. Operating income was TWD 32.674 million compared to operating loss of TWD 68.335 million a year ago. Net income was TWD 23.428 million compared to net loss of TWD 67.897 million a year ago. Basic earnings per share was TWD 0.34 compared to basic loss per share of TWD 1.04 a year ago.